IPD2.09 Lumacaftor/ivacaftor improves 6 minute walk test distance, FEV1 and reduces exacerbations in severe cystic fibrosis lung disease
T. Thiruchelvam
◽
K. Cookson
◽
P. Wark
◽
D. Dorahy
2019 ◽
Vol 156
(4)
◽
pp. A1126
Kevin Mange
◽
Kevin Roberts
◽
Anthe Zandvliet
◽
Han Witjes
◽
Marta Neve
◽
...
Benjamin Raby
◽
Angela Rogers
1985 ◽
Vol 19
(4)
◽
pp. 398A-398A
H Auerbach
◽
M Williams
◽
H R Colten
2014 ◽
Vol 11
(1)
◽
pp. 63-72
◽
Don B. Sanders
◽
Zhanhai Li
◽
Anita Laxova
◽
Michael J. Rock
◽
Hara Levy
◽
...
2009 ◽
Vol 458
(7241)
◽
pp. 1039-1042
◽
YuanYuan Gu
◽
Isaac T. W. Harley
◽
Lindsay B. Henderson
◽
Bruce J. Aronow
◽
Ilja Vietor
◽
...
2009 ◽
Vol 136
(4)
◽
pp. 9S
Dayton Dmello
◽
Dana Oliver
◽
Ravi Nayak
2017 ◽
Vol 72
(12)
◽
pp. 1104-1112
◽
Katherine B Frayman
◽
David S Armstrong
◽
Rosemary Carzino
◽
Thomas W Ferkol
◽
Keith Grimwood
◽
...
2012 ◽
Vol 185
(8)
◽
pp. 862-873
◽
Yvonne Belessis
◽
Barbara Dixon
◽
Glenn Hawkins
◽
John Pereira
◽
Jenny Peat
◽
...
2016 ◽
Vol 8
(4)
◽
pp. e1408
Roopa Biswas
◽
Parameet Kumar
◽
Harvey B. Pollard
1999 ◽
Vol 116
(5)
◽
pp. 1494
◽
Shinji Teramoto
◽
Takeshi Mastsue
◽
Yasuyoshi Ouchi